Sally Ann Huntoon Vitali, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 7 | 2018 | 1534 | 0.960 |
Why?
|
| Heme Oxygenase-1 | 2 | 2019 | 381 | 0.810 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 664 | 0.510 |
Why?
|
| Inflammasomes | 1 | 2019 | 496 | 0.500 |
Why?
|
| Death | 1 | 2015 | 678 | 0.380 |
Why?
|
| Status Epilepticus | 1 | 2014 | 444 | 0.340 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2009 | 171 | 0.330 |
Why?
|
| Bilirubin | 2 | 2009 | 425 | 0.310 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 896 | 0.300 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1171 | 0.300 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 1354 | 0.280 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 1775 | 0.280 |
Why?
|
| Tissue Donors | 1 | 2015 | 2241 | 0.270 |
Why?
|
| Pulmonary Artery | 4 | 2021 | 1911 | 0.260 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2004 | 80 | 0.240 |
Why?
|
| Lung | 3 | 2019 | 9858 | 0.220 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2004 | 214 | 0.220 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 1503 | 0.220 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7880 | 0.210 |
Why?
|
| Carbon Monoxide | 1 | 2005 | 531 | 0.210 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3679 | 0.210 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 18027 | 0.210 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2021 | 56 | 0.200 |
Why?
|
| Critical Care | 1 | 2014 | 2647 | 0.200 |
Why?
|
| Sepsis | 3 | 2022 | 2593 | 0.200 |
Why?
|
| Exosomes | 2 | 2018 | 419 | 0.190 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2018 | 496 | 0.180 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 263 | 0.170 |
Why?
|
| Caspase 1 | 1 | 2019 | 224 | 0.170 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2020 | 142 | 0.160 |
Why?
|
| Interleukin-18 | 1 | 2019 | 249 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 4326 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 612 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 1199 | 0.130 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2018 | 1632 | 0.120 |
Why?
|
| Pentobarbital | 1 | 2014 | 155 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 305 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 973 | 0.120 |
Why?
|
| Mice | 8 | 2021 | 81154 | 0.120 |
Why?
|
| Respiration, Artificial | 1 | 2004 | 2568 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 530 | 0.110 |
Why?
|
| Midazolam | 1 | 2014 | 270 | 0.110 |
Why?
|
| Critical Illness | 2 | 2023 | 2670 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 1178 | 0.110 |
Why?
|
| Acidosis, Respiratory | 1 | 2012 | 37 | 0.100 |
Why?
|
| Pyrroles | 1 | 2018 | 1147 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2217 | 0.100 |
Why?
|
| Isoflurane | 1 | 2014 | 380 | 0.100 |
Why?
|
| Animals | 13 | 2021 | 168660 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2019 | 2500 | 0.090 |
Why?
|
| Airway Remodeling | 1 | 2012 | 132 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6380 | 0.090 |
Why?
|
| Vasoconstriction | 2 | 2012 | 597 | 0.090 |
Why?
|
| Indoles | 1 | 2018 | 1841 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 2274 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2021 | 2029 | 0.090 |
Why?
|
| Anesthetics, Inhalation | 1 | 2014 | 569 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 752 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2005 | 3308 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 380 | 0.080 |
Why?
|
| Ketamine | 1 | 2014 | 501 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 2037 | 0.080 |
Why?
|
| Infant, Newborn | 6 | 2023 | 25609 | 0.080 |
Why?
|
| Tidal Volume | 2 | 2013 | 490 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2020 | 3458 | 0.080 |
Why?
|
| Macrophages | 2 | 2019 | 5651 | 0.080 |
Why?
|
| Analgesics | 1 | 2014 | 1040 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 1161 | 0.070 |
Why?
|
| Biliverdine | 1 | 2005 | 29 | 0.070 |
Why?
|
| Positive-Pressure Respiration | 2 | 2013 | 633 | 0.070 |
Why?
|
| Vasodilation | 1 | 2009 | 944 | 0.070 |
Why?
|
| Child | 8 | 2023 | 77637 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21824 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 688 | 0.060 |
Why?
|
| Oxygenators, Membrane | 1 | 2004 | 56 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2014 | 1910 | 0.060 |
Why?
|
| High-Frequency Ventilation | 1 | 2004 | 87 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 17439 | 0.060 |
Why?
|
| Rats | 4 | 2021 | 24250 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77410 | 0.060 |
Why?
|
| Cell Death | 1 | 2009 | 1705 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1826 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
| Quality Control | 1 | 2005 | 841 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Sheep | 1 | 2004 | 1437 | 0.050 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1991 | 43 | 0.050 |
Why?
|
| Monocrotaline | 2 | 2012 | 26 | 0.050 |
Why?
|
| Heart Failure | 2 | 2023 | 10896 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2022 | 405 | 0.050 |
Why?
|
| Random Allocation | 2 | 2018 | 2429 | 0.050 |
Why?
|
| HLA-A Antigens | 1 | 1991 | 232 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2009 | 2132 | 0.050 |
Why?
|
| Partial Thromboplastin Time | 1 | 2021 | 206 | 0.050 |
Why?
|
| Infant | 4 | 2023 | 35122 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1631 | 0.050 |
Why?
|
| Biopsy, Needle | 2 | 2018 | 1639 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 8300 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 380 | 0.040 |
Why?
|
| Humans | 18 | 2023 | 743811 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 570 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10629 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2021 | 40964 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 329 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 1991 | 880 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 23398 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2004 | 778 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2004 | 981 | 0.040 |
Why?
|
| Epoprostenol | 1 | 2018 | 254 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 2 | 2012 | 642 | 0.040 |
Why?
|
| Platelet Count | 1 | 2020 | 780 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5216 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9731 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 2047 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 1991 | 2419 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21733 | 0.030 |
Why?
|
| Hyperoxia | 1 | 2018 | 262 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 12944 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3874 | 0.030 |
Why?
|
| Catheterization | 1 | 2020 | 1469 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 855 | 0.030 |
Why?
|
| Heparin | 1 | 2021 | 1637 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2018 | 541 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 1615 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10477 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9718 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 4737 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 4221 | 0.030 |
Why?
|
| Ammonium Chloride | 1 | 2012 | 73 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2725 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 2012 | 74 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11360 | 0.030 |
Why?
|
| Nitroprusside | 1 | 2012 | 275 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2013 | 438 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2012 | 301 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 537 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 278 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2005 | 9139 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40038 | 0.020 |
Why?
|
| Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3317 | 0.020 |
Why?
|
| Alleles | 1 | 1991 | 6934 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 569 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20121 | 0.020 |
Why?
|
| Male | 8 | 2023 | 349776 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2012 | 619 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2009 | 183 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3953 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2013 | 729 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 873 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 9944 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 1150 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2922 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2971 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9848 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 19894 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2241 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14563 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4599 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5316 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4974 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12786 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 974 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15211 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13404 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 63042 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6356 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1888 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 13869 | 0.010 |
Why?
|
| Female | 5 | 2023 | 380020 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 4584 | 0.010 |
Why?
|
| Swine | 1 | 2013 | 5909 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14714 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2012 | 4162 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 213889 | 0.010 |
Why?
|
| Pneumonia | 1 | 2012 | 2133 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 53250 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1991 | 354 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3817 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40545 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 19232 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 4775 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2012 | 3750 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2012 | 8551 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29777 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2005 | 2961 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72252 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 85729 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1991 | 6170 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163178 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213241 | 0.000 |
Why?
|